Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 31.3B | 15.3B | 19.8B | 13.6B |
Cost of revenue | 16.5B | 7.4B | 10.8B | 6.6B |
Gross profit | 14.8B | 7.9B | 8.9B | 7.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.7B | 2.6B | 2.3B | 3.1B |
Operating income | 9.4B | 3.6B | 4.6B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1B | 939M | 935.1M | 1.0B |
Other income expense | — | — | — | — |
Pretax income | 10.5B | 1.7B | 5.8B | 4.6B |
Tax provision | 1.8B | -2.7B | -4.7B | 1.2B |
Net income | 12.8B | 10.6B | 13.8B | 6.4B |
Basic EPS | — | 4.3 | 5.6 | 2.6 |
Diluted EPS | — | 4.3 | 5.6 | 2.6 |
Basic average shares | — | 2.5B | 2.5B | 2.5B |
Diluted average shares | — | 2.5B | 2.5B | 2.5B |
EBITDA | 12.0B | 6.1B | 7.1B | 6.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | -1.4M | 9.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |